SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-125287
Filing Date
2022-04-28
Accepted
2022-04-28 07:02:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d297953ddefa14a.htm DEFA14A 11461
2 GRAPHIC g297953dsp063.jpg GRAPHIC 363868
3 GRAPHIC g297953dsp064.jpg GRAPHIC 243785
  Complete submission text file 0001193125-22-125287.txt   849625
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36352 | Film No.: 22862127
SIC: 2834 Pharmaceutical Preparations